By targeting both pathways at once, Tirzepatide produces a more comprehensive metabolic effect than GLP-1 alone
GLP-1 therapy works the same way for many patients, managing a metabolic condition rather than curing it
Study procedure (Koide et al., 2025) GLP-1RA therapy significantly reduced blood glucose levels, body weight, and body fat percentage Results showed that after 12 months of treatment, GLP-1RA therapy significantly reduced participants blood glucose levels (as measured by glycated hemoglobin), body weight, and body fat percentage
The FDA approved a pill version of Wegovy on Dec
In Canada, anabolic steroids are classified as Schedule IV controlled substances under the Controlled Drugs and Substances Act
A pivotal 2021 clinical trial of semaglutide showed that participants lost an average of 15% of their body weight over 68 weeks, compared to just 2% in the placebo group